1. Home
  2. LEGN vs WH Comparison

LEGN vs WH Comparison

Compare LEGN & WH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • WH
  • Stock Information
  • Founded
  • LEGN 2014
  • WH 2017
  • Country
  • LEGN United States
  • WH United States
  • Employees
  • LEGN N/A
  • WH N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • WH Hotels/Resorts
  • Sector
  • LEGN Health Care
  • WH Consumer Discretionary
  • Exchange
  • LEGN Nasdaq
  • WH Nasdaq
  • Market Cap
  • LEGN 7.0B
  • WH 6.5B
  • IPO Year
  • LEGN 2020
  • WH N/A
  • Fundamental
  • Price
  • LEGN $31.78
  • WH $84.26
  • Analyst Decision
  • LEGN Strong Buy
  • WH Strong Buy
  • Analyst Count
  • LEGN 13
  • WH 11
  • Target Price
  • LEGN $79.42
  • WH $108.07
  • AVG Volume (30 Days)
  • LEGN 1.5M
  • WH 981.7K
  • Earning Date
  • LEGN 05-13-2025
  • WH 04-30-2025
  • Dividend Yield
  • LEGN N/A
  • WH 1.94%
  • EPS Growth
  • LEGN N/A
  • WH 48.31
  • EPS
  • LEGN N/A
  • WH 4.22
  • Revenue
  • LEGN $627,241,000.00
  • WH $1,416,000,000.00
  • Revenue This Year
  • LEGN $65.96
  • WH $9.62
  • Revenue Next Year
  • LEGN $52.55
  • WH $7.02
  • P/E Ratio
  • LEGN N/A
  • WH $20.05
  • Revenue Growth
  • LEGN 119.97
  • WH 2.61
  • 52 Week Low
  • LEGN $29.27
  • WH $67.67
  • 52 Week High
  • LEGN $60.87
  • WH $113.07
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 41.49
  • WH 46.16
  • Support Level
  • LEGN $30.25
  • WH $82.99
  • Resistance Level
  • LEGN $35.81
  • WH $84.96
  • Average True Range (ATR)
  • LEGN 1.45
  • WH 2.49
  • MACD
  • LEGN -0.18
  • WH 0.43
  • Stochastic Oscillator
  • LEGN 27.58
  • WH 53.46

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About WH Wyndham Hotels & Resorts Inc.

As of Dec. 31, 2024, Wyndham Hotels & Resorts operates 903,000 rooms across more than 20 brands predominantly in the economy and midscale segments. Super 8 is the largest brand, representing around 18% of all rooms, with Days Inn (13%) and Ramada (14%) the next two largest brands. During the past several years, the company has expanded its extended stay/lifestyle brands, which appeal to travelers seeking to experience the local culture of a given location. The company closed its La Quinta acquisition in the second quarter of 2018, adding around 90,000 rooms at the time the deal closed. Wyndham launched a new extended stay economy scale segment concept, ECHO, in the spring of 2022. The United States represents 56% of total rooms.

Share on Social Networks: